1. Home
  2. NOTE vs ANTX Comparison

NOTE vs ANTX Comparison

Compare NOTE & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FiscalNote Holdings Inc.

NOTE

FiscalNote Holdings Inc.

HOLD

Current Price

$1.90

Market Cap

39.9M

Sector

Technology

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$1.17

Market Cap

30.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOTE
ANTX
Founded
2013
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.9M
30.1M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
NOTE
ANTX
Price
$1.90
$1.17
Analyst Decision
Strong Buy
Buy
Analyst Count
4
1
Target Price
$29.25
$2.00
AVG Volume (30 Days)
238.6K
54.2K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$102,673,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.83
$1.01
52 Week High
$24.36
$1.59

Technical Indicators

Market Signals
Indicator
NOTE
ANTX
Relative Strength Index (RSI) 27.09 60.86
Support Level $1.88 $1.03
Resistance Level $2.15 $1.12
Average True Range (ATR) 0.19 0.06
MACD 0.04 0.01
Stochastic Oscillator 10.88 100.00

Price Performance

Historical Comparison
NOTE
ANTX

About NOTE FiscalNote Holdings Inc.

FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Share on Social Networks: